The primary endpoint was the risk reduction between the 5-day and 10-day PAXLOVID regimens versus placebo in the proportion of subjects who developed RT-PCR or RAT-confirmed symptomatic SARS-CoV-2 infection through Day 14 who had a negative SARS-CoV-2 RT-PCR result at baseline
(PubMed) Banka S, Ryan K, Thomson W, Newman WG
Dit rapport
Skin types that benefit most from GHK-Cu as a retinoid alternative include rosacea-prone, post-procedure, eczema-affected, and mature skin that reacts poorly to retinol
This is an enzyme that uses glutathione to lower oxidative damage in tissues, so selenium indirectly affects the antioxidative action of glutathione
Current Research Evidence and Clinical Applications GHK-Cu has been studied for wound healing, skin aging, hair growth, and tissue regeneration